5HT2C- The primary receptor for advanced neuro therapies Neurological disorders are on the rise, and the few existing drugs in the market are either not effective in healing patients or have severe side effects. This article looks at a couple of 5HT compounds approved by the FDA, their impact on patients and how the Bright Minds Biosciences’ (CSE:DRUG) 5HT2C superagonist leads the treatment race for a range of neurological problems. We also look at the various next-gen proprietary 5HT2C compounds in the pipeline and the different stages of progress in the trials.
Before we go into the drug details, here’s an overview and the functions of the 5HT2C receptors- 5HT receptors are also called 5-hydroxytryptamine, or serotonin receptors. Activated by the neurotransmitter serotonin, the receptors are primarily in the central and peripheral nervous system. Serotonin receptors activate several neurological processes such as learning, mood, sleep, nausea, anxiety, aggression, appetite and others.
Source:https://www.takestockresearch.com/blog/5ht2c-primary-receptor-advanced-neuro-therapies